Issue link: https://www.e-digitaleditions.com/i/1509086
50 Pharmaceutical Technology ® Trends in Formulation 2023 eBook PharmTech.com CPHI BarCelona Coverage CPHI Barcelona Agenda*—Day One ROOM: 4.3; CONFERENCE CENTRE 4 Track: Next-Gen Biomanufacturing Innovative manufacturing technologies and approaches for bringing biologics to market Track Chair: Eduard Ayuso, Chief Executive Officer, Dinamiqs Keynote Address 11:00–11:15 Setting the Scene for the Biomanufacturing Landscape Sheila Ann Mikhail, Co-Founder and Former CEO, Asklepios BioPharmaceutical, Inc Overcoming Challenges in Transferring a Sterile Biologics Drug Product to a CDMO 11:15–11:35 Speaker: Olaf Wegener, Head of Research & Development, Siegfried Hameln GmbH Building a Collaborative Supply Chain for Biological Products: A Roadmap for the Future 11:40–12:00 Speaker: Magnus Blomberg, Global Supply Network Strategy Director, AstraZeneca Biologics Capability and Capacity Expansion Driving the Shift to CRDMO Business Models 12:05–12:25 Speaker: Unmesh Lal, Director, Frost & Sullivan Process Optimization for Viral Vector Manufacturing 12:30–12:50 Speaker: Eduard Ayuso, Chief Executive Officer, Dinamiqs Panel: Strategies for Commercialising Cell and Gene Therapies 12:55–13:40 Moderator: Eduard Ayuso, Chief Executive Officer, Dinamiqs Panellists: Sheila Ann Mikhail, Co-Founder and Former CEO, Asklepios BioPharmaceutical, Inc; Unmesh Lal, Director, Frost & Sullivan; Magnus Blomberg, Global Supply Network Strategy Director, AstraZeneca ROOM: 4.4; CONFERENCE CENTRE 4 Track: Formulating the Future Addressing formulation challenges for the therapies of the future Track Chair: Ljiljana Palangetic, Associate Director, R&D Hard Capsules, Lonza Capsules and Health Ingredients Keynote Address 11:00–11:15 Setting the Scene for Drug Formulation Challenges and Opportunities Hubert Gambs, Deputy Director-General and SME Coordinator, European Commission Strategies for Formulating Future Drug Modalities 11:15–11:35 Speaker: Camille Dumont, Manager, Customer Applications – Application Lab, Lonza Capsules and Health Ingredients Leverage the Benefit of Drug Delivery and Formulation to Achieve Acceptability in the Target Patient Population 11:40–12:00 Speaker: Sven Stegemann, CEO, Leibniz JointLab Implications of FDA's Quality Maturity Model (QMM) Initiative for API Manufacturers, Drug Sponsors and Drug Manufacturers 12:05–12:25 Speaker: Sireesha Yadlapalli, CEO, Pharmatech Associates The Future of EU Off-Patent API Manufacturing 12:30 – 12:50 Speaker: Markus Sieger, Vice President, Medicines for Europe Panel: Looking to the Future– What's Next for the Generic Drugs Market? 12:55–13:40 Moderator: Camille Dumont, Manager, Customer Applications – Application Lab, Lonza Capsules and Health Ingredients Panellists: Juan Colberg, Senior Director Technology & Innovation, Global Green Chemistry Leader, Pfizer; Sven Stegemann, CEO, Leibniz JointLab; Markus Sieger, Vice President, Medicines for Europe; Sireesha Yadlapalli, CEO, Pharmatech Associates Lunch and Networking 13:40 ROOM: 4.3; CONFERENCE CENTRE 4 Track: Partnering for Success Exploring the dynamics of partner selection, collaboration, and diversification Track Chair: Anil Kane, PhD, MBA, Global Head of Technical & Scientific Affairs, Thermo Fisher Scientific Keynote Address 14:00–14:15 Setting the Scene for the CDMO Landscape Vinay Saluja, Global Head Development Services, Global Biotech Cooperations, CDMO, Novartis CDMO 2.0: Uncovering the Missing Element in Next-Generation Pharma Partnerships 14:15–14:35 Speaker: Anil Kane, Ph.D., MBA Global Head of Technical & Scientific Affairs, Thermo Fisher Scientific CDMO Selection for the Biotech: A Practical Guide 14:40–15:00 Speaker: Julien Laizé, Head of Global CTM External Manufacturing, Valneva Case Study: Embracing the Modern CDMO in Pharma 15:05–15:25 Speaker: Shilpi Ghosh, CDMO Site Management Chapter Lead (Infectious Disease, Immunology, Ophthalmology), Roche Managing Outsourcing Relationships to Optimise Manufacturing Operations 15:30–15:50 Speaker: Federica Fraschetti, Associate Director - Focus Factory Leader, MSD Panel: The CDMO Outlook 15:55 - 16:45 Moderator: Gil Roth, President, PBOA Panellists: Federica Fraschetti, Associate Director - Focus Factory Leader, MSD; Shilpl Ghosh, Chapter Leader, I2O, CDMO, Roche; Raman Sehgal, Founder and Host, Molecule to Market Podcast; Anil Kane, PhD, MBA Global Head of Technical & Scientific Affairs, Thermo Fisher Scientific ROOM: 4.4; CONFERENCE CENTRE 4 Track: Creating a Circular Economy The realities of establishing a sustainable future for pharma Track Chair: Pieter Van Gool, Business development Manager, SUDPACK Medica Keynote Address 14:00–14:15 Setting the Scene for Sustainability in Pharma Giulia Usai, Senior Director Procurement Sustainability, GSK Unlocking Value: Paving the Path of a Committed Value Chain With PP 14:15–14:35 Speaker: Jürgen Bodenmüller, Director of Business Development SUDPACK Medica; Paulo Cavacas, Business Development Manager Healthcare, Borealis Decarbonising Chemical Supply Chains Including the Product Carbon Footprint Guideline 14:40–15:00 Speaker: Mathias Lemke, Senior Director and Head of Sourcing Raw Packaging Material, Merck Darmstadt Promoting Circularity in Packaging: The Sustainable Packaging Model from Ferrer 15:05–15:25 Speaker: Berta Mota, Head of Circular Economy, Anthesis Group Víctor Cañadas, Sustainability Advisor, Ferrer Putting ESG into Practice – Creating Responsible Supply Chains via Common Audit Approaches 15:30–15:50 Speaker: Enric Bosch Rado, Global Third party manager Chemicals Manager / Human Pharma supply chain, Boehringer Ingelheim Panel: How Pharma Can Build a Meaningful Circular Economy 15:55–16:45 Moderator: Jürgen Bodenmüller, Director of Business Development SUDPACK Medica Panellists: Berta Mota, Head of Circular Economy, Anthesis Group; Enric Bosch Rado, Global Third party manager Chemicals Manager/Human Pharma supply chain, Boehringer Ingelheim; Paulo Cavacas, Business Development Manager Healthcare, Borealis